
Enzo Biochem ENZ
Quartalsbericht 2024-Q3
hinzugefügt 16.12.2024
Enzo Biochem DSO 2011-2026 | ENZ
DSO Jährlich Enzo Biochem
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.3 | 56.2 | 83.6 | 30 | 47.7 | 48.3 | 45.8 | 51.4 | 51.8 | 70.2 | 47.4 | 47.9 | 50 | 54.5 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 83.6 | 30 | 52.5 |
DSO Vierteljährlich Enzo Biochem
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57.5 | - | 51.5 | 49.6 | 52.5 | - | 152 | 163 | 148 | 21.8 | 41.5 | 31.4 | 37 | 15.5 | 26.6 | 49.3 | 33.7 | 21.1 | 33.1 | 50.9 | 46.5 | 24.9 | 61.3 | 47.1 | 55.8 | 22.6 | 61.2 | 51.8 | 48.8 | 26.4 | 47.3 | 50 | 49.7 | 26.8 | 45.8 | 48.5 | 45.1 | 23.1 | 43.4 | 48.2 | 45.7 | 24.2 | 46 | 54 | 49.2 | 23.4 | 48.6 | 50.1 | 50.1 | 25.4 | 25.2 | 28.2 | 53 | 28.2 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 163 | 15.5 | 47.3 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Anixa Biosciences
ANIX
|
275 | $ 3.04 | -1.94 % | $ 98.7 K | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Burning Rock Biotech Limited
BNR
|
31.7 | $ 33.99 | 0.65 % | $ 366 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
BioNano Genomics
BNGO
|
83.4 | $ 1.45 | -1.36 % | $ 1.84 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 38.58 | -1.48 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
101 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
57 | $ 220.11 | 0.3 % | $ 161 B | ||
|
Exact Sciences Corporation
EXAS
|
29.9 | $ 102.53 | 0.22 % | $ 19 B | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 26.1 | -0.55 % | $ 789 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Guardant Health
GH
|
49.2 | $ 111.68 | 1.09 % | $ 13.7 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
85 | $ 73.38 | -0.84 % | $ 28.3 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 20.61 | -0.91 % | $ 1.11 B | ||
|
DarioHealth Corp.
DRIO
|
85.8 | $ 11.0 | 6.8 % | $ 312 M | ||
|
Lantheus Holdings
LNTH
|
72 | $ 66.0 | -1.02 % | $ 4.57 B | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
61.3 | $ 147.19 | -1.67 % | $ 23.4 B | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
78 | $ 230.76 | -2.0 % | $ 41.8 B | ||
|
NeoGenomics
NEO
|
77.8 | $ 12.08 | -2.58 % | $ 1.53 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 210.0 | -0.83 % | $ 10.8 B | ||
|
Medpace Holdings
MEDP
|
51.5 | $ 584.19 | -1.5 % | $ 18.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 184.39 | 1.14 % | $ 20.5 B | ||
|
Biodesix
BDSX
|
41.7 | $ 9.1 | -5.8 % | $ 1.18 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
28.1 | $ 24.39 | 0.54 % | $ 31.7 M | ||
|
Laboratory Corporation of America Holdings
LH
|
54.1 | $ 269.89 | 0.03 % | $ 22.6 B | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 392.56 | -0.02 % | $ 29.6 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 177.62 | -4.45 % | $ 14.7 B | ||
|
IDEXX Laboratories
IDXX
|
43.6 | $ 676.0 | -0.1 % | $ 55.7 B | ||
|
Personalis
PSNL
|
55.8 | $ 9.44 | -5.37 % | $ 559 M | ||
|
Agilent Technologies
A
|
63.8 | $ 133.08 | -0.12 % | $ 40.5 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.35 | -1.67 % | $ 5.4 M |